Literature DB >> 10463079

An antisense oligonucleotide primer.

R I Hogrefe1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10463079     DOI： 10.1089/oli.1.1999.9.351

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN： 1087-2906


× No keyword cloud information.
  6 in total

1.  Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells.

Authors:  A N Elayadi; A Demieville; E V Wancewicz; B P Monia; D R Corey
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

2.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.

Authors:  B Herbert; A E Pitts; S I Baker; S E Hamilton; W E Wright; J W Shay; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 3.  Personalized cancer approach: using RNA interference technology.

Authors:  John Nemunaitis; Donald D Rao; Shi-He Liu; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 4.  In vivo imaging with oligonucleotides for diagnosis and drug development.

Authors:  B Tavitian
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

Review 5.  Morpholino antisense oligonucleotides: tools for investigating vertebrate development.

Authors:  D R Corey; J M Abrams
Journal:  Genome Biol       Date:  2001-04-26       Impact factor: 13.583

6.  Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs.

Authors:  Keith T Gagnon; David R Corey
Journal:  Nucleic Acid Ther       Date:  2019-03-23       Impact factor: 5.486
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.